(Q40963061)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

H Mazarguil

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

B Monsarrat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

B Van den Eynde

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J E Gairin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

10227-10234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

Tumor antigens recognized by T lymphocytes

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Peptide-induced antiviral protection by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

MHC ligands and peptide motifs: first listing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues. Implications for peptide selection and presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Structure of the complex between human T-cell receptor, viral peptide and HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

T cell priming versus T cell tolerance induced by synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Relative implication of peptide residues in binding to major histocompatibility complex class I H-2Db: application to the design of high-affinity, allele-specific peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Peptide-based cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Peptide stability in drug development: a comparison of peptide reactivity in different biological media

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Getting some "backbone": how MHC binds peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Efficient binding of reduced peptide bond pseudopeptides to major histocompatibility complex class I molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Probing immunogenicity of a T cell epitope by L-alanine and D-amino acid scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

Topological mimicry of cross-reacting enantiomeric peptide antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.15.10227

21 January 2018

Identifiers

DOI

10.1074/JBC.274.15.10227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10187808%20AND%20SRC:MED&resulttype=core&format=json

release_j66ttxqra5fybdqodxfo55aewa

3 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j66ttxqra5fybdqodxfo55aewa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference